Tommy Schornak
Senior Vice President, Injectables, Kindeva
False
Advertisement
The GLP-1 Capacity Squeeze
September 16, 2026
As demand for GLP-1 medicines grows, injectable manufacturers must increase output without compromising quality or squeezing supply for other therapies
4 min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
